Global Heart Transplantation Therapeutics Market 2025-2029
Description
Heart Transplantation Therapeutics Market 2025-2029
The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's heart transplantation therapeutics market is segmented as below:
By Drug Class
The report on the heart transplantation therapeutics market covers the following areas:
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's heart transplantation therapeutics market is segmented as below:
By Drug Class
- Immunosuppressants
- Anti-infectives
- Analgesics
- Others
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- Left ventricular assist device (LVAD)
- Heart transplantation
- Implantable cardiac defibrillator (ICD)
- Extracorporeal membrane oxygenation (ECMO)
- Ischemic heart disease (IHD)
- Dilated cardiomyopathy (DCM)
- Valvular heart disease (VHD)
- Hypertrophic cardiomyopathy (HCM)
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the heart transplantation therapeutics market covers the following areas:
- Heart Transplantation Therapeutics Market sizing
- Heart Transplantation Therapeutics Market forecast
- Heart Transplantation Therapeutics Market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
252 Pages
- Market overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Criticality of inputs and Factors of differentiation
- Factors of disruption
- Impact of drivers and challenges
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2024
- Market outlook: Forecast for 2024-2029
- Global Heart Transplantation Therapeutics Market 2019 - 2023
- Drug Class segment analysis 2019 - 2023
- Distribution Channel segment analysis 2019 - 2023
- Type segment analysis 2019 - 2023
- Indication segment analysis 2019 - 2023
- Geography segment analysis 2019 - 2023
- Country segment analysis 2019 - 2023
- Impact of AI in global heart transplantation therapeutics market
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Drug Class
- Immunosuppressants - Market size and forecast 2024-2029
- Anti-infectives - Market size and forecast 2024-2029
- Analgesics - Market size and forecast 2024-2029
- Others - Market size and forecast 2024-2029
- Market opportunity by Drug Class
- Market segments
- Comparison by Distribution Channel
- Hospital pharmacies - Market size and forecast 2024-2029
- Retail pharmacies - Market size and forecast 2024-2029
- Online pharmacies - Market size and forecast 2024-2029
- Market opportunity by Distribution Channel
- Market segments
- Comparison by Type
- Left ventricular assist device (LVAD) - Market size and forecast 2024-2029
- Heart transplantation - Market size and forecast 2024-2029
- Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029
- Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024- 2029
- Market opportunity by Type
- Market segments
- Comparison by Indication
- Ischemic heart disease (IHD) - Market size and forecast 2024-2029
- Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029
- Valvular heart disease (VHD) - Market size and forecast 2024-2029
- Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029
- Market opportunity by Indication
- Customer landscape overview
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2024-2029
- Europe - Market size and forecast 2024-2029
- Asia - Market size and forecast 2024-2029
- Rest of World (ROW) - Market size and forecast 2024-2029
- US - Market size and forecast 2024-2029
- Germany - Market size and forecast 2024-2029
- Canada - Market size and forecast 2024-2029
- France - Market size and forecast 2024-2029
- Japan - Market size and forecast 2024-2029
- UK - Market size and forecast 2024-2029
- India - Market size and forecast 2024-2029
- China - Market size and forecast 2024-2029
- South Korea - Market size and forecast 2024-2029
- Italy - Market size and forecast 2024-2029
- Market opportunity by geography
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market opportunities/restraints
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
- Companies profiled
- Company ranking index
- Market positioning of companies
- AbbVie Inc.
- Astellas Pharma Inc.
- Biocon Ltd.
- Dr Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
- LEO Pharma AS
- Lupin Ltd.
- Novartis AG
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Scope of the report
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
